Expandable stents and method for making same

Information

  • Patent Grant
  • 7513907
  • Patent Number
    7,513,907
  • Date Filed
    Friday, April 22, 2005
    19 years ago
  • Date Issued
    Tuesday, April 7, 2009
    15 years ago
Abstract
The invention is directed to an expandable stent for implantation in a body lumen, such as an artery, and a method for making it from a single length of tubing. The stent consists of a plurality of radially expandable cylindrical elements generally aligned on a common axis and interconnected by one or more interconnective elements. The individual radially expandable cylindrical elements consist of ribbon-like material disposed in an undulating pattern. Portions of the expanded stent project outwardly into engagement with the vessel wall to more securely attach the stent.
Description
BACKGROUND OF THE INVENTION

This invention relates to expandable endoprosthesis devices, generally called stents, which are adapted to be implanted into a patient's body lumen, such as blood vessel, to maintain the patency thereof. These devices are very useful in the treatment of atherosclerotic stenosis in blood vessels.


Stents are generally tubular-shaped devices which function to hold open a segment of a blood vessel or other anatomical lumen. They are particularly suitable for use to support and hold back a dissected arterial lining which can occlude the fluid passageway therethrough.


Further details of prior art stents can be found in U.S. Pat. No. 3,868,956 (Alfidi et al.); U.S. Pat. No. 4,512,338 (Balko et al.); U.S. Pat. No. 4,553,545 (Maass et al.); U.S. Pat. No. 4,733,665 (Palmaz); U.S. Pat. No. 4,762,128 (Rosenbluth); U.S. Pat. No. 4,800,882 (Gianturco); U.S. Pat. No. 4,856,516 (Hillstead); and U.S. Pat. No. 4,886,062 (Wiktor), which are hereby incorporated herein in their entirety by reference thereto.


Various means have been described to deliver and implant stents. One method frequently described for delivering a stent to a desired intraluminal location includes mounting the expandable stent on an expandable member, such as a balloon, provided on the distal end of an intravascular catheter, advancing the catheter to the desired location within the patient's body lumen, inflating the balloon on the catheter to expand the stent into a permanent expanded condition and then deflating the balloon and removing the catheter. One of the difficulties encountered using prior stents involved maintaining the radial rigidity needed to hold open a body lumen while at the same time maintaining the longitudinal flexibility of the stent to facilitate its delivery.


What has been needed and heretofore unavailable is a stent which has a high degree of flexibility so that it can be advanced through tortuous passageways and can be readily expanded and yet have the mechanical strength to hold open the body lumen into which it expanded. The present invention satisfies this need.


SUMMARY OF THE INVENTION

The present invention is directed to an expandable stent which is relatively flexible along its longitudinal axis to facilitate delivery through tortuous body lumens, but which is stiff and stable enough radially in an expanded condition to maintain the patency of a body lumen such as an artery when implanted therein.


The stent of the invention generally includes a plurality of radially expandable cylindrical elements which are relatively independent in their ability to expand and to flex relative to one another. The individual radially expandable cylindrical elements of the stent are dimensioned so as to be longitudinally shorter than their own diameters. Interconnecting elements or struts extending between adjacent cylindrical elements provide increased stability and a preferable position to prevent warping of the stent upon the expansion thereof. The resulting stent structure is a series of radially expandable cylindrical elements which are spaced longitudinally close enough so that small dissections in the wall of a body lumen may be pressed back into position against the lumenal wall, but not so close as to compromise the longitudinal flexibilities of the stent. The individual cylindrical elements may rotate slightly relative to adjacent cylindrical elements without significant deformation, cumulatively giving a stent which is flexible along its length and about its longitudinal axis but is still very stiff in the radial direction in order to resist collapse.


The stent embodying features of the invention can be readily delivered to the desired lumenal location by mounting it on an expandable member of a delivery catheter, for example a balloon, and passing the catheter-stent assembly through the body lumen to the implantation site. A variety of means for securing the stent to the expandable member on the catheter for delivery to the desired location are available. It is presently preferred to compress the stent onto the balloon. Other means to secure the stent to the balloon include providing ridges or collars on the inflatable member to restrain lateral movement, or using bioresorbable temporary adhesives.


The presently preferred structure for the expandable cylindrical elements which form the stents of the present invention generally circumferential undulating pattern, e.g. serpentine. The transverse cross-section of the undulating component of the cylindrical element is relatively small and preferably has an aspect ratio of about two to one to about 0.5 to one. A one to one aspect ratio has been found particularly suitable. The open reticulated structure of the stent allows for the profusion of blood over a large portion of the arterial wall which can improve the healing and repair of a damaged arterial lining.


The radial expansion of the expandable cylinder deforms the undulating pattern thereof similar to changes in a waveform which result from decreasing the waveform's amplitude and the frequency. Preferably, the undulating patterns of the individual cylindrical structures are in phase with each other in order to prevent the contraction of the stent along its length when it is expanded. The cylindrical structures of the stent are plastically deformed when expanded (except with NiTi alloys) so that the stent will remain in the expanded condition and therefore they must be sufficiently rigid when expanded to prevent the collapse thereof in use. During expansion of the stent, portions of the undulating pattern will tip outwardly resulting in projecting members on the outer surface of the expanded stent. These projecting members tip radially outwardly from the outer surface of the stent and embed in the vessel wall and help secure the expanded stent so that it does not move once it is implanted.


With superelastic NiTi alloys, the expansion occurs when the stress of compression is removed so as to allow the phase transformation from austenite back to martensite and as a result the expansion of the stent.


The elongated elements which interconnect adjacent cylindrical elements should have a transverse cross-section similar to the transverse dimensions of the undulating components of the expandable cylindrical elements. The interconnecting elements may be formed in a unitary structure with the expandable cylindrical elements from the same intermediate product, such as a tubular element, or they may be formed independently and connected by suitable means, such as by welding or by mechanically securing the ends of the interconnecting elements to the ends of the expandable cylindrical elements. Preferably, all of the interconnecting elements of a stent are joined at either the peaks or the valleys of the undulating structure of the cylindrical elements which for the stent. In this manner there is no shortening of the stent upon expansion.


The number and location of elements interconnecting adjacent cylindrical elements can be varied in order to develop the desired longitudinal flexibility in the stent structure both in the unexpanded as well as the expanded condition. These properties are important to minimize alteration of the natural physiology of the body lumen into which the stent is implanted and to maintain the compliance of the body lumen which is internally supported by the stent. Generally, the greater the longitudinal flexibility of the stent, the easier and the more safely it can be delivered to the implantation site.


In a presently preferred embodiment of the invention the stent is conveniently and easily formed by coating stainless steel tubing with a material resistant to chemical etching, removing portions of the coating to expose portions of underlying tubing which are to be removed to develop the desired stent structure. The exposed portions of the tubing are removed by chemically etching from the tubing exterior leaving the coated portion of the tubing material in the desired pattern of the stent structure. The etching process develops smooth openings in the tubing wall without burrs or other artifacts which are characteristic of mechanical or laser machining processes in the small sized products contemplated. Moreover, a computer controlled laser patterning process to remove the chemical resistive coating makes photolithography technology adaptable to the manufacture of these small products. The forming of a mask in the extremely small sizes needed to make the small stents of the invention would be a most difficult task. A plurality of stents can be formed from one length of tubing by repeating the stent pattern and providing small webs or tabs to interconnect the stents. After the etching process, the stents can be separated by severing the small webs or tabs which connect them.


Other features and advantages of the present invention will become more apparent from the following detailed description of the invention. When taken in conjunction with the accompanying exemplary drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is an elevational view, partially in section, of a stent embodying features of the invention which is mounted on a delivery catheter and disposed within a damaged artery.



FIG. 2 is an elevational view, partially in section, similar to that shown in FIG. 1 wherein the stent is expanded within a damaged artery, pressing the damaged lining against the arterial wall.



FIG. 3 is an elevational view, partially in section showing the expanded stent within the artery after withdrawal of the delivery catheter.



FIG. 4 is a perspective view of a stent embodying features of the invention in an unexpanded state, with one end of the stent being shown in an exploded view illustrate the details thereof.



FIG. 5 is a plan view of a flattened section of a stent of the invention which illustrates the undulating pattern of the stent shown in FIG. 4.



FIG. 6 is a schematic representation of equipment for selectively removing coating applied to tubing in the manufacturing of the stents of the present invention.



FIGS. 7 through 10 are perspective views schematically illustrating various configurations of interconnective element placement between the radially expandable cylindrical elements of the stent.



FIG. 11 is a plan view of a flattened section of a stent illustrating an alternate undulating pattern in the expandable cylindrical elements of the stent which are out of phase.



FIG. 12 is an enlarged partial view of the stent of FIG. 5 with the various members slightly expanded.



FIG. 13 is a perspective view of the stent of FIG. 4 after it is fully expanded depicting some members projecting radially outwardly.



FIG. 14 is an enlarged, partial perspective view of one U-shaped member with its tip projecting outwardly after expansion.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS


FIG. 1 illustrates a stent 10 incorporating features of the invention which is mounted onto a delivery catheter 11. The stent generally comprises a plurality of radially expandable cylindrical elements 12 disposed generally coaxially and interconnected by elements 13 disposed between adjacent cylindrical elements. The delivery catheter 11 has an expandable portion or balloon 14 for expanding of the stent 10 within an artery 15. The artery 15, as shown in FIG. 1 has a dissected lining 16 which has occluded a portion of the arterial passageway.


The delivery catheter 11 onto which the stent 10 is mounted, is essentially the same as a conventional balloon dilatation catheter for angioplasty procedures. The balloon 14 may be formed of suitable materials such as polyethylene, polyethylene terephthalate, polyvinyl chloride, nylon and ionomers such as Surlyn® manufactured by the Polymer Products Division of the Du Pont Company. Other polymers may also be used. In order for the stent 10 to remain in place on the balloon 14 during delivery to the site of the damage within the artery 15, the stent 10 is compressed onto the balloon. A retractable protective delivery sleeve 20 as described in co-pending application Ser. No. 07/647,464 filed on Apr. 25, 1990 and entitled STENT DELIVERY SYSTEM may be provided to further ensure that the stent stays in place on the expandable portion of the delivery catheter 11 and prevent abrasion of the body lumen by the open surface of the stent 20 during delivery to the desired arterial location. Other means for securing the stent 10 onto the balloon 14 may also be used, such as providing collars or ridges on the ends of the working portion, i.e. the cylindrical portion, of the balloon.


Each radially expandable cylindrical element 12 of the stent 10 may be independently expanded. Therefore, the balloon 14 may be provided with an inflated shape other than cylindrical, e.g. tapered, to facilitate implantation of the stent 10 in a variety of body lumen shapes.


In a preferred embodiment, the delivery of the stent 10 is accomplished in the following manner. The stent 10 is first mounted onto the inflatable balloon 14 on the distal extremity of the delivery catheter 11. The balloon 14 is slightly inflated to secure the stent 10 onto the exterior of the balloon. The catheter-stent assembly is introduced within the patient's vasculature in a conventional Seldinger technique through a guiding catheter (not shown). A guidewire 18 is disposed across the damaged arterial section with the detached or dissected lining 16 and then the catheter-stent assembly is advanced over a guidewire 18 within the artery 15 until the stent 10 is directly under the detached lining 16. The balloon 14 of the catheter is expanded, expanding the stent 10 against the artery 15, which is illustrated in FIG. 2. While not shown in the drawing, the artery 15 is preferably expanded slightly by the expansion of the stent 10 to seat or otherwise fix the stent 10 to prevent movement. In some circumstances during the treatment of stenotic portions of an artery, the artery may have to be expanded considerably in order to facilitate passage of blood or other fluid therethrough.


The stent 10 serves to hold open the artery 15 after the catheter 11 is withdrawn, as illustrated by FIG. 3. Due to the formation of the stent 10 from elongated tubular member, the undulating component of the cylindrical elements of the stent 10 is relatively flat in transverse cross-section, so that when the stent is expanded, the cylindrical elements are pressed into the wall of the artery 15 and as a result do not interfere with the blood flow through the artery 15. The cylindrical elements 12 of stent 10 which are pressed into the wall of the artery 15 will eventually be covered with endothelial cell growth which further minimizes blood flow interference. The undulating portion of the cylindrical sections 12 provide good tacking characteristics to prevent stent movement within the artery. Furthermore, the closely spaced cylindrical elements 12 at regular intervals provide uniform support for the wall of the artery 15, and consequently are well adapted to tack up and hold in place small flaps or dissections in the wall of the artery 15 as illustrated in FIGS. 2 and 3.



FIG. 4 is an enlarged perspective view of the stent 10 shown in FIG. 1 with one end of the stent shown in an exploded view to illustrate in greater detail the placement of interconnecting elements 13 between adjacent radially expandable cylindrical elements 12. Each pair of the interconnecting elements 13 on one side of a cylindrical element 12 are preferably placed to achieve maximum flexibility for a stent. In the embodiment shown in FIG. 4 the stent 10 has three interconnecting elements 13 between adjacent radially expandable cylindrical elements 12 which are 120 degrees apart. Each pair of interconnecting elements 13 on one side of a cylindrical element 12 are offset radially 60 degrees from the pair on the other side of the cylindrical element. The alternation of the interconnecting elements results in a stent which is longitudinally flexible in essentially all directions. Various configurations for the placement of interconnecting elements are possible, and several examples are illustrated schematically in FIGS. 7-10. However, as previously mentioned, all of the interconnecting elements of an individual stent should be secured to either the peaks or valleys of the undulating structural elements in order to prevent shortening of the stent during the expansion thereof.



FIG. 10 illustrates a stent of the present invention wherein three interconnecting elements 12 are disposed between radially expandable cylindrical elements 11. The interconnecting elements 12 are distributed radially around the circumference of the stent at a 120-degree spacing. Disposing four or more interconnecting elements 13 between adjacent cylindrical elements 12 will generally give rise to the same considerations discussed above for two and three interconnecting elements.


The properties of the stent 10 may also be varied by alteration of the undulating pattern of the cylindrical elements 13. FIG. 11 illustrates an alternative stent structure in which the cylindrical elements are in serpentine patterns but out of phase with adjacent cylindrical elements. The particular pattern and how many undulations per unit of length around the circumference of the cylindrical element 13, or the amplitude of the undulations, are chosen to fill particular mechanical requirements for the stent such as radial stiffness.


The number of undulations may also be varied to accommodate placement of interconnecting elements 13, e.g. at the peaks of the undulations or along the sides of the undulations as shown in FIGS. 5 and 11.


In keeping with the invention, and with reference to FIGS. 4 and 12-14, cylindrical elements 12 are in the form of a serpentine pattern 30. As previously mentioned, each cylindrical element 12 is connected by interconnecting elements 13. Serpentine pattern 30 is made up of a plurality of U-shaped members 31, W-shaped members 32, and Y-shaped members 33, each having a different radius so that expansion forces are more evenly distributed over the various members.


As depicted in FIGS. 13 and 14, after cylindrical elements 12 have been radially expanded, outwardly projecting edges 34 are formed. That is, during radial expansion U-shaped members 31 will tip outwardly thereby forming outwardly projecting edges. These outwardly projecting edges provide for a roughened outer wall surface of stent 10 and assist in implanting the stent in the vascular wall by embedding into the vascular wall. In other words, outwardly projecting edges embed into the vascular wall, for example artery 15, as depicted in FIG. 3. Depending upon the dimensions of stent 10 and the thickness of the various members making up the serpentine pattern 30, any of the U-shaped members 31, W-shaped members 32, and Y-shaped members 33 can tip radially outwardly to form a projecting edge 34. It is most likely and preferred that U-shaped members 31 tip outwardly since they do not join with any connecting member 13 to prevent them from expanding outwardly.


The stent 10 of the present invention can be made in many ways. However, the preferred method of making the stent is to coat a thin-walled tubular member, such as stainless steel tubing, with a material which is resistive to chemical etchants, remove portions of the coating to expose underlying tubing which is to be removed but to leave coated portions of the tubing in the desired pattern for the stent so that subsequent etching will remove the exposed portions of the metallic tubing, but will leave relatively untouched the portions of the metallic tubing which are to form the stent. The coated portion of the metallic tube is in the desired shape for the stent. An etching process avoids the necessity of removing burrs or slag inherent in conventional or laser machining process. It is preferred to remove the etchant-resistive material by means of a machine-controlled laser as illustrated schematically in FIG. 6.


A coating is applied to a length of tubing which, when cured, is resistive to chemical etchants. “Blue Photoresist” made by the Shipley Company in San Jose, Calif., is an example of suitable commercially available photolithographic coatings. The coating is preferably applied by electrophoretic deposition.


To ensure that the surface finish is reasonably uniform, one of the electrodes used for the electrochemical polishing is a doughnut-shaped electrode which is placed about the central portion of the tubular member.


The tubing may be made of suitable biocompatible material such as stainless steel, titanium, tantalum, superelastic NiTi alloys and even high strength thermoplastic polymers. The stent diameter is very small, so the tubing from which it is made must necessarily also have a small diameter. Typically the stent has an outer diameter on the order of about 0.06 inch in the unexpanded condition, the same outer diameter of the tubing from which it is made, and can be expanded to an outer diameter of 0.1 inch or more. The wall thickness of the tubing is about 0.003 inch. In the instance when the stent was plastic, it would have to be heated within the arterial site where the stent is expanded to facilitate the expansion of the stent. Once expanded, it would then be cooled to retain its expanded state. The stent may be conveniently heated by heating the fluid within the balloon or the balloon directly by a suitable system such as disclosed in a co-pending application Ser. No. 07/521,337, filed Jan. 26, 1990 entitled DILATATION CATHETER ASSEMBLY WITH HEATED BALLOON which is incorporated herein in its entirety by reference. The stent may also be made of materials such as superelastic NiTi alloys such as described in co-pending application Ser. No. 07/629,381, filed Dec. 18, 1990, entitled SUPERELASTIC GUIDING MEMBER which is incorporated herein in its entirety by reference. In this case the stent would be formed full size but deformed (e.g. compressed) into a smaller diameter onto the balloon of the delivery catheter to facilitate transfer to a desired intraluminal site. The stress induced by the deformation transforms the stent from a martensite phase to an austenite phase and upon release of the force, when the stent reaches the desired intraluminal location, allows the stent to expand due to the transformation back to the martensite phase.


Referring to FIG. 6, the coated tubing 21 is put in a rotatable collet fixture 22 of a machine controlled apparatus 23 for positioning the tubing 21 relative to a laser 24. According to machine-encoded instructions, the tubing 21 is rotated and moved longitudinally relative to the laser 24 which is also machine controlled. The laser selectively removes the etchant-resistive coating on the tubing by ablation and a pattern is formed such that the surface of the tube that is to be removed by a subsequent chemical etching process is exposed. The surface of the tube is therefore left coated in the discrete pattern of the finished stent.


A presently preferred system for removing the coating on the tubing includes the use an 80-watt CO2 laser, such as a Coherent Model 44, in pulse mode (0.3 mS pulse length); 48 mA key current and 48 W key power with 0.75 W average power, at 100 Hz; Anorad FR=20; 12.5 Torr; with no assist gas. Low pressure air is directed through the fine focus head to ensure that no vapor contacts the lens. The assist gas jet assembly on the laser unit may be removed to allow a closer proximity of the fine focus head and the collet fixture. Optimum focus is set at the surface of the tubing. Cured photo-resist coating readily absorbs the energy of the CO2 wavelength, so that it can be readily removed by the laser. A coated 4-inch length of 0.06 inch stainless steel tubing is preferred and four stents can be patterned on the length of tubing. Three tabs or webs between stents provide good handling characteristics for the tubing after the etching process.


The process of patterning the resistive coating on the stent is automated except for loading and unloading the length of tubing. Referring again to FIG. 6 it may be done, for example, using a CNC-opposing collet fixture 22 for axial rotation of the length of tubing, in conjunction with a CNC X/Y table 25 to move the length of tubing axially relative to a machine-controlled laser as described. The entire space between collets can be patterned using the CO2 laser set-up of the foregoing example. The program for control of the apparatus is dependent on the particular configuration used and the pattern to be ablated in the coating, but is otherwise conventional.


This process makes possible the application of present photolithography technology in manufacturing the stents. While there is presently no practical way to mask and expose a tubular photo-resist coated part of the small size required for making intravascular stents, the foregoing steps eliminate the need for conventional masking techniques.


After the coating is thus selectively ablated, the tubing is removed from the collet fixture 22. Next, wax such at ThermoCote N-4 is heated to preferably just above its melting point, and inserted into the tubing under vacuum or pressure. After the wax has solidified upon cooling, it is reheated below its melting point to allow softening, and a smaller diameter stainless steel shaft is inserted into the softened wax to provide support. The tubing is then etched chemically in a conventional manner. After cutting the tabs connecting the stents any surface roughness or debris from the tabs is removed. The stents are preferably electrochemically polished in an acidic aqueous solution such as a solution of ELECTRO-GLO #300, sold by the ELECTRO-GLO CO., Inc. in Chicago, Ill., which is a mixture of sulfuric acid, carboxylic acids, phosphates, corrosion inhibitors and a biodegradable surface active agent. The bath temperature is maintained at about 110-135 degrees F. and the current density is about 0.4 to about 1.5 amps per in.2 Cathode to anode area should be at least about two to one. The stents may be further treated if desired, for example by applying a biocompatible coating.


While the invention has been illustrated and described herein in terms of its use as an intravascular stent, it will be apparent to those skilled in the art that the stent can be used in other instances such as to expand prostatic urethras in cases of prostate hyperplasia. Other modifications and improvements may be made without departing from the scope of the invention.


Other modifications and improvements can be made to the invention without departing from the scope thereof.

Claims
  • 1. A method of chemically etching a metallic member to form an intravascular stent, comprising: applying a photoresistive coating to a metallic surface of the metallic member;selectively removing portions of the photoresistive coating from the metallic surface thereby providing exposed portions of the metallic surface and protected portions of the metallic surface;exposing the metallic surface to a chemical etchant solution thereby removing a full thickness of the metallic member to form a pattern generally corresponding to the exposed portions of the metallic surface;removing the photoresistive coating; andelectrochemically polishing the metallic member in a solution having at least an acid and a corrosion inhibitor.
  • 2. The method of claim 1, wherein the metallic surface is curved and selective removal of portions of the resistive coating from the curved metallic surface provides the stent pattern.
  • 3. The method of claim 2, wherein the curved metallic surface is in the form of a tubular member and the photoresistive coating is applied to an outer surface of the tubular member.
  • 4. The method of claim 3, wherein prior to removing selected portions of the photoresistive coating, inserting a substance into the tubular member to protect an inner surface of the tubular member from the chemical etchant solution.
  • 5. The method of claim 4, wherein softened wax is inserted into the tubular member.
RELATED APPLICATIONS

This application is a division of U.S. Ser. No. 10/427,514 filed May 1, 2003 now U.S. Pat. No. 6,908,479 which is a division of U.S. Ser. No. 09/779,078 filed Feb. 8, 2001 now U.S. Pat. No. 6,596,022, which is a division of U.S. Ser. No. 09/561,098 filed Apr. 28, 2000 now U.S. Pat. No. 6,309,412, which is a division of U.S. Ser. No. 09/135,222 filed Aug. 17, 1998 now U.S. Pat. No. 6,056,776, which is a division of U.S. Ser. No. 09/055,582 filed Apr. 6, 1998 now U.S. Pat. No. 6,066,168, which is a division of U.S. Ser. No. 08/783,097 filed Jan. 14, 1997, now U.S. Pat. No. 5,735,893, which is a division of U.S. Ser. No. 08/556,516, filed Nov. 13, 1995, now U.S. Pat. No. 5,603,721, which is a division of U.S. Ser. No. 08/281,790, filed Jul. 28, 1994, now U.S. Pat. No. 5,514,154, which is a continuation in part of U.S. Ser. No. 08/164,986 filed Dec. 9, 1993, now abandoned, which is a continuation of Ser. No. 07/783,558, filed Oct. 28, 1991, now abandoned.

US Referenced Citations (229)
Number Name Date Kind
2701559 Cooper Feb 1955 A
3105492 Jeckel Oct 1963 A
3657744 Ersek Apr 1972 A
3868956 Alfidi et al. Mar 1975 A
3993078 Bergentz et al. Nov 1976 A
4130904 Whalen Dec 1978 A
4140126 Choudhyry Feb 1979 A
4159719 Haerr Jul 1979 A
4241146 Sivachenko et al. Dec 1980 A
4323071 Simpson et al. Apr 1982 A
4387952 Slusher Jun 1983 A
4503569 Dotter Mar 1985 A
4504354 George et al. Mar 1985 A
4512338 Balko et al. Apr 1985 A
4516972 Samson May 1985 A
4531933 Norton et al. Jul 1985 A
4553545 Maass et al. Nov 1985 A
4560374 Hammerslag Dec 1985 A
4580568 Gianturco Apr 1986 A
4616652 Simpson Oct 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4649922 Wiktor Mar 1987 A
4650466 Luther Mar 1987 A
4655771 Wallsten Apr 1987 A
4665906 Jervis May 1987 A
4665918 Garza et al. May 1987 A
4681110 Wiktor Jul 1987 A
4706671 Weinrib Nov 1987 A
4725334 Brimm Feb 1988 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4740207 Kreamer Apr 1988 A
4748982 Horzewski et al. Jun 1988 A
4760849 Kropf Aug 1988 A
4762128 Rosenbluth Aug 1988 A
4767418 Deininter Aug 1988 A
4768507 Fischell et al. Sep 1988 A
4776337 Palmaz Oct 1988 A
4795458 Regan Jan 1989 A
4800882 Gianturco Jan 1989 A
4830003 Wolff et al. May 1989 A
4848343 Wallsten et al. Jul 1989 A
4856516 Hillstead Aug 1989 A
4870966 Dellon et al. Oct 1989 A
4877030 Beck et al. Oct 1989 A
4878906 Lindemann et al. Nov 1989 A
4886062 Wiktor Dec 1989 A
4887997 Okada Dec 1989 A
4892539 Koch Jan 1990 A
4893623 Rosenbluth Jan 1990 A
4907336 Gianturco Mar 1990 A
4913141 Hillstead Apr 1990 A
4921479 Grayzel May 1990 A
4922905 Strecker May 1990 A
4923464 DiPisa, Jr. May 1990 A
4943346 Mattelin Jul 1990 A
4950227 Savin et al. Aug 1990 A
4963022 Sommargren Oct 1990 A
4969458 Wiktor Nov 1990 A
4969890 Sugita et al. Nov 1990 A
4986831 King et al. Jan 1991 A
4988356 Crittenden et al. Jan 1991 A
4990155 Wilkoff Feb 1991 A
4994071 MacGregor Feb 1991 A
4998539 Delsanti Mar 1991 A
5002560 Machold et al. Mar 1991 A
5007926 Derbyshire Apr 1991 A
5015253 MacGregor May 1991 A
5019085 Hillstead May 1991 A
5019090 Pinchuk May 1991 A
5026377 Burton et al. Jun 1991 A
5034001 Garrison et al. Jul 1991 A
5035706 Gianturco et al. Jul 1991 A
5037377 Alonso Aug 1991 A
5037392 Hillstead Aug 1991 A
5037427 Harada et al. Aug 1991 A
5041126 Gianturco Aug 1991 A
5059211 Stack et al. Oct 1991 A
5061273 Yock Oct 1991 A
5061275 Wallsten et al. Oct 1991 A
5062829 Pryor et al. Nov 1991 A
5064435 Porter Nov 1991 A
5067957 Jervis Nov 1991 A
5071407 Termin et al. Dec 1991 A
5073694 Tessier et al. Dec 1991 A
5078726 Kreamer Jan 1992 A
5078736 Behl Jan 1992 A
5084065 Weldon et al. Jan 1992 A
5089005 Harada Feb 1992 A
5089006 Stiles Feb 1992 A
5092877 Pinchuk Mar 1992 A
5100429 Sinofsly et al. Mar 1992 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5108416 Ryan et al. Apr 1992 A
5108417 Sawyer Apr 1992 A
5116318 Hillstead May 1992 A
5116360 Pinchuk et al. May 1992 A
5116365 Hillstead May 1992 A
5122154 Rhodes Jun 1992 A
5123917 Lee Jun 1992 A
5133732 Wiktor Jul 1992 A
5135536 Hillstead Aug 1992 A
5158548 Lau et al. Oct 1992 A
5161547 Tower Nov 1992 A
5163952 Froix Nov 1992 A
5163958 Pinchuk Nov 1992 A
5171262 MacGregor Dec 1992 A
5180368 Garrison Jan 1993 A
5183085 Timmermans Feb 1993 A
5192297 Hull Mar 1993 A
5192307 Wall Mar 1993 A
5192311 King et al. Mar 1993 A
5195984 Schatz Mar 1993 A
5197978 Hess Mar 1993 A
5217482 Keith Jun 1993 A
5222971 Willard et al. Jun 1993 A
5226913 Pinchuk Jul 1993 A
5234456 Silverstini Aug 1993 A
5242397 Barath et al. Sep 1993 A
5242399 Lau et al. Sep 1993 A
5242452 Inoue Sep 1993 A
5282823 Schwartz et al. Feb 1994 A
5282824 Gianturco Feb 1994 A
5290295 Querals et al. Mar 1994 A
5290305 Inoue Mar 1994 A
5292331 Boneau Mar 1994 A
5304200 Spaulding Apr 1994 A
5314444 Gianturco May 1994 A
5314472 Fontaine May 1994 A
5330500 Song Jul 1994 A
5344425 Sawyer Sep 1994 A
5344426 Lau et al. Sep 1994 A
5354308 Simon et al. Oct 1994 A
5356433 Rowland et al. Oct 1994 A
5360401 Turnlund Nov 1994 A
5368566 Crocker Nov 1994 A
5372600 Beyar et al. Dec 1994 A
5378239 Termin et al. Jan 1995 A
5383892 Cardon et al. Jan 1995 A
5395390 Simon et al. Mar 1995 A
5405378 Strecker Apr 1995 A
5413597 Krajicek May 1995 A
5421955 Lau Jun 1995 A
5423745 Todd et al. Jun 1995 A
5423885 Williams Jun 1995 A
5445646 Euteneuer et al. Aug 1995 A
5449373 Pinchasik Sep 1995 A
5456694 Marin et al. Oct 1995 A
5458615 Klemm et al. Oct 1995 A
5476476 Hillstead Dec 1995 A
5476506 Lunn et al. Dec 1995 A
5484449 Amundson et al. Jan 1996 A
5507768 Lau et al. Apr 1996 A
5514154 Lau et al. May 1996 A
5527324 Krantz et al. Jun 1996 A
5545132 Fagan et al. Aug 1996 A
5569295 Lam Oct 1996 A
5571135 Fraser et al. Nov 1996 A
5603721 Lau et al. Feb 1997 A
5626604 Cottone et al. May 1997 A
5653690 Booth et al. Aug 1997 A
5653691 Rupp et al. Aug 1997 A
5653727 Wiktor Aug 1997 A
5693089 Inoue Dec 1997 A
5716393 Lindenberg et al. Feb 1998 A
5716396 Williams Feb 1998 A
5720726 Marcadis et al. Feb 1998 A
5733303 Israel Mar 1998 A
5733325 Robinson Mar 1998 A
5741327 Frantzen Apr 1998 A
5746765 Kleshinski et al. May 1998 A
5776161 Globerman Jul 1998 A
5782855 Lau et al. Jul 1998 A
5800521 Orth Sep 1998 A
5800526 Anderson et al. Sep 1998 A
5810868 Lashinski et al. Sep 1998 A
5810871 Tuckey et al. Sep 1998 A
5817152 Birdsall Oct 1998 A
5827321 Roubin et al. Oct 1998 A
5830217 Ryan Nov 1998 A
5836965 Jendersee et al. Nov 1998 A
5836966 St. Germain Nov 1998 A
5855600 Alt Jan 1999 A
5861027 Trap Jan 1999 A
5902332 Schatz May 1999 A
5906640 Penn et al. May 1999 A
5911754 Kanesaka et al. Jun 1999 A
5922021 Jang Jul 1999 A
5925061 Ogi et al. Jul 1999 A
5938697 Killion et al. Aug 1999 A
5948016 Jang Sep 1999 A
5954743 Jang Sep 1999 A
5980552 Pinchasik et al. Nov 1999 A
5984964 Roberts et al. Nov 1999 A
5997468 Wolff et al. Dec 1999 A
6010530 Goicoechea Jan 2000 A
6017365 Von Oepen Jan 2000 A
6030413 Lazarus Feb 2000 A
6033435 Penn et al. Mar 2000 A
6042597 Kveen et al. Mar 2000 A
6042606 Frantzen Mar 2000 A
6048361 Von Oepen Apr 2000 A
6059822 Kanesaka et al. May 2000 A
6066167 Lau et al. May 2000 A
6066168 Lau et al. May 2000 A
6071298 Lashinski et al. Jun 2000 A
6071308 Ballou et al. Jun 2000 A
6106548 Roubin et al. Aug 2000 A
6146358 Rowe Nov 2000 A
6146403 St. Germain Nov 2000 A
6159238 Killion et al. Dec 2000 A
6179867 Cox Jan 2001 B1
6183506 Penn et al. Feb 2001 B1
6200337 Moriuchi et al. Mar 2001 B1
6206910 Berry et al. Mar 2001 B1
6217608 Penn et al. Apr 2001 B1
6231598 Berry et al. May 2001 B1
6273901 Whitcher et al. Aug 2001 B1
6273910 Limon Aug 2001 B1
6273911 Cox Aug 2001 B1
6287336 Globerman et al. Sep 2001 B1
6340366 Wijay Jan 2002 B2
6344055 Shukov Feb 2002 B1
6468302 Cox et al. Oct 2002 B2
6852124 Cox et al. Feb 2005 B2
20010029397 Thompson Oct 2001 A1
20010041929 Von Oepen Nov 2001 A1
20020007212 Brown et al. Jan 2002 A1
Foreign Referenced Citations (149)
Number Date Country
A-2378488 Apr 1989 AU
B-6133390 Feb 1991 AU
B5319894 Mar 1994 AU
B-5319894 Mar 1994 AU
513567 Nov 1971 CH
2001535 Jul 1970 DE
1665771 Jan 1971 DE
2301075 Jul 1973 DE
2410933 Sep 1974 DE
118673 Mar 1976 DE
2708945 Sep 1978 DE
2920223 Nov 1980 DE
3205942 Sep 1983 DE
3516862 Nov 1986 DE
36 40 745 Jun 1987 DE
3640745 Jun 1987 DE
3722749 Jan 1988 DE
38 23 060 Jan 1989 DE
3823060 Jan 1989 DE
3724479 Feb 1989 DE
69029114 Nov 1996 DE
195 37 872 Apr 1997 DE
19537872 Apr 1997 DE
0062300 Oct 1982 EP
0 201 466 Apr 1986 EP
0177330 Apr 1986 EP
0177453 Apr 1986 EP
0183372 Jun 1986 EP
0190543 Aug 1986 EP
0 221 570 May 1987 EP
0221570 May 1987 EP
0256986 Feb 1988 EP
0274846 Jul 1988 EP
0282175 Sep 1988 EP
0 380 668 Oct 1988 EP
0290138 Nov 1988 EP
0308512 Mar 1989 EP
0312852 Apr 1989 EP
0 338 816 Oct 1989 EP
0335341 Oct 1989 EP
0338816 Oct 1989 EP
0357003 Mar 1990 EP
0 361 192 Apr 1990 EP
0 364 787 Apr 1990 EP
0361192 Apr 1990 EP
0364787 Apr 1990 EP
0 372 789 Jun 1990 EP
0372789 Jun 1990 EP
0380668 Aug 1990 EP
0 407 951 Jan 1991 EP
0 408 245 Jan 1991 EP
0407951 Jan 1991 EP
0408245 Jan 1991 EP
0417928 Mar 1991 EP
0 421 729 Apr 1991 EP
0 423 916 Apr 1991 EP
0421729 Apr 1991 EP
0423916 Apr 1991 EP
0 428 479 May 1991 EP
0428471 May 1991 EP
0428479 May 1991 EP
0483372 May 1992 EP
0 517 075 Sep 1992 EP
0 062 300 Oct 1992 EP
0517075 Dec 1992 EP
0 540 290 May 1993 EP
0 540 290 May 1993 EP
0 541 443 May 1993 EP
0 541 443 May 1993 EP
0540290 May 1993 EP
0541443 May 1993 EP
0 606 165 Jul 1994 EP
0 688 545 Dec 1995 EP
0729767 Sep 1996 EP
0 417 928 Nov 1996 EP
0417928 Dec 1996 EP
0 800 801 Oct 1997 EP
1571240 Jun 1969 FR
2476524 Aug 1981 FR
2 677 872 Dec 1992 FR
2677872 Dec 1992 FR
1205743 Sep 1970 GB
1583192 Jan 1981 GB
2 070 490 Sep 1981 GB
2070490 Sep 1981 GB
2092894 Aug 1982 GB
2135585 Nov 1983 GB
2 135 585 Sep 1984 GB
58-501458 Sep 1983 JP
60-500520 Apr 1985 JP
61-41444 Feb 1986 JP
62-213762 Sep 1987 JP
62-231657 Oct 1987 JP
62-235496 Oct 1987 JP
62-235496 Oct 1987 JP
62235496 Oct 1987 JP
63-214264 Sep 1988 JP
63-246178 Oct 1988 JP
63-289990 Nov 1988 JP
64-83685 Mar 1989 JP
64-83685 Mar 1989 JP
1-145076 Jun 1989 JP
1-299550 Dec 1989 JP
2-174859 Jul 1990 JP
2-255157 Oct 1990 JP
3-9745 Jan 1991 JP
3-9745 Jan 1991 JP
3-9746 Jan 1991 JP
3-9746 Jan 1991 JP
3-57465 Mar 1991 JP
3-151983 Jun 1991 JP
4-25755 Feb 1992 JP
5-267998 Oct 1993 JP
79208 Oct 1979 LU
660689 May 1979 SU
764684 Sep 1980 SU
1084091 Apr 1984 SU
1217402 Mar 1986 SU
1457921 Feb 1989 SU
WO 8303752 Nov 1983 WO
WO 8303752 Nov 1983 WO
WO 8400121 Jan 1984 WO
WO 8901798 Mar 1989 WO
WO 8901798 Mar 1989 WO
WO 8908433 Sep 1989 WO
WO 8908433 Sep 1989 WO
WO 9107139 May 1991 WO
WO 9107139 May 1991 WO
WO 9117720 Nov 1991 WO
WO 9206734 Apr 1992 WO
WO 9206734 Apr 1992 WO
WO 9209246 Jun 1992 WO
WO 9209246 Jun 1992 WO
WO 9417754 Aug 1994 WO
WO 9417754 Aug 1994 WO
WO 9523563 Sep 1995 WO
WO 9523563 Sep 1995 WO
WO 9526695 Oct 1995 WO
WO 9526695 Oct 1995 WO
WO 9609013 Mar 1996 WO
WO 9609013 Mar 1996 WO
WO 9626689 Sep 1996 WO
WO 9626689 Sep 1996 WO
WO 9822159 May 1998 WO
WO 9822159 May 1998 WO
WO 9848734 Nov 1998 WO
WO 9848734 Nov 1998 WO
WO 9902105 Jan 1999 WO
WO 9902105 Jan 1999 WO
Related Publications (1)
Number Date Country
20050192663 A1 Sep 2005 US
Divisions (8)
Number Date Country
Parent 10427514 May 2003 US
Child 11112143 US
Parent 09779078 Feb 2001 US
Child 10427514 US
Parent 09561098 Apr 2000 US
Child 09779078 US
Parent 09135222 Aug 1998 US
Child 09561098 US
Parent 09055582 Apr 1998 US
Child 09135222 US
Parent 08783097 Jan 1997 US
Child 09055582 US
Parent 08556516 Nov 1995 US
Child 08783097 US
Parent 08281790 Jul 1994 US
Child 08556516 US
Continuations (1)
Number Date Country
Parent 07783558 Oct 1991 US
Child 08164986 US
Continuation in Parts (1)
Number Date Country
Parent 08164986 Dec 1993 US
Child 08281790 US